InMed Pharmaceuticals Inc. announced the appointment of Catherine Sazdanoff, JD, to its Board of Directors. Ms. Sazdanoff joins InMed's Board with 35 years of experience in the healthcare industry. She held various global VP roles in business development and corporate development at Takeda Pharmaceuticals, which she joined in 2006. Prior to Takeda, Ms. Sazdanoff served in senior global legal and pharmaceutical business roles at Abbott Laboratories since 1984, including litigation, international commercial and transactional legal roles, marketing, and business development. Ms. Sazdanoff is an independent director of the Board of Meridian Bioscience Inc. She is currently President and CEO of Sazdanoff Consulting LLC, where she acts as Business Advisor to Strata Oncology Inc.